Clinical Trial

Anxiolytic Effect of Virtual Reality Immersion Versus Midazolam Premedication in Patients Undergoing Dacryocystorhinostomy Surgery

Recruiting
View on ClinicalTrials.gov →
Record status
This record was last updated July 3, 2025 (before its estimated December 30, 2025 completion). Its status may not reflect the trial's current state.
Summary
The aim is to investigate the anxiolytic effect, and hemodynamic stability of using virtual reality immersion in adult patients undergoing Dacryocystorhinostomy (DCR) operation under general anesthesia and to compare its effect to that of using Midazolam as a premedication.
Trial Details
NCT Number NCT07050095
Lead Sponsor Cairo University
Conditions Anxiolytic Effect, Virtual Reality Immersion, Midazolam, Premedication, Dacryocystorhinostomy
Enrollment 40 participants
Start Date 2025-06-01
Primary Completion 2025-12-30 (estimated)
Study Completion 2025-12-30 (estimated)
Updated on ClinicalTrials.gov 2025-07-03